Century Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-73,494
Closed -$3.93M – 228
2016
Q1
$3.93M Sell
73,494
-147,293
-67% -$10.9M 0.43% 107
2015
Q4
$24.9M Buy
220,787
+20,016
+10% +$2.21M 1.43% 16
2015
Q3
$23.6M Sell
200,771
-41,083
-17% -$5.37M 1.34% 13
2015
Q2
$18.7M Sell
241,854
-241,586
-50% -$15.8M 1.06% 35
2015
Q1
$28M Sell
483,440
-63,603
-12% -$2.7M 1.61% 14
2014
Q4
$17.6M Buy
547,043
+238,561
+77% +$7.16M 1.02% 36
2014
Q3
$7.55M Buy
+308,482
New +$6.27M 0.45% 67

Other funds holding ANAC

Century Capital Management's ANAC Position: Q2 2016 in Review

Century Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 73,494 shares — an estimated $3.93M sold.

Century Capital Management first reported a position in ANAC in Q3 2014 and held it in 7 quarters. The position peaked at $28M in Q1 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Century Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Century Capital Management sold 73,494 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $3.93M.
  • Century Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 7 quarters.
  • Century Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $28M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Century Capital Management's 13F filing for Q2 2016, filed 10 Aug 2016.